GlassScriptPhysician profile
Allen S Greenbaum
NPI 1891739728
$9,569.90
in general payments reported to CMS, 2019-2025
37 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $1,015 · 2021: $1,091 · 2022: $1,224 · 2023: $1,060 · 2024: $2,151 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,745.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,060.16 | 2019-2025 | Rocklatan, Rhopressa, Clareon |
| Abbvie INC. | $1,135.34 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $971.85 | 2019-2025 | Cequa |
| Rxsight INC | $654.50 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $577.02 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $473.03 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $450.00 | 2019-2024 | Tecnis Iol, Catalys System, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $445.34 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $444.23 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Allergan, INC. | $369.96 | 2019-2022 | |
| Alimera Sciences, INC. | $243.01 | 2020-2024 | Iluvien, Yutiq |
| Amgen INC. | $177.36 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $159.00 | 2022-2024 | Tyrvaya |
| Shockwave Medical, INC | $138.01 | 2021 | |
| Astellas Pharma US INC | $132.34 | 2023-2025 | Izervay |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Greenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.